Home › Funds › Sanders Capital, LLC › ELV
Sanders Capital, LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Sanders Capital, LLC reported holding 5,830,605 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$2.27B, representing 2.20% of its reported portfolio and ranking #14 among its reported holdings. Sanders Capital, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sanders Capital, LLC's ELV position evolved
Sanders Capital, LLC first disclosed a stake in ELV in Q3 2023 at 4,261,976 shares (US$1.86B). The position peaked in Q2 2024 at 4,564,453 shares, worth US$2.47B. Across 13 filings, Sanders Capital, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 5,830,605 shares valued at US$2.27B.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.26M | $1.86B | New |
| Q4 2023 | 4.46M | $2.10B | Add |
| Q1 2024 | 4.51M | $2.34B | Add |
| Q2 2024 | 4.56M | $2.47B | Add |
| Q3 2024 | 4.61M | $2.40B | Add |
| Q4 2024 | 4.69M | $1.73B | Add |
| Q1 2025 | 4.67M | $2.03B | Hold |
| Q2 2025 | 5.83M | $2.27B | Add |
| Q3 2025 | 5.77M | $1.86B | Reduce |
| Q4 2025 | 5.75M | $2.02B | Hold |
| Q1 2026 | 5.89M | $1.73B | Add |
| Q2 2026 | 5.83M | $2.25B | Reduce |
| Q3 2026 | 5.83M | $2.27B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 22 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Harris Associates (Oakmark) (US$1.90B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Sanders Capital, LLC
FAQ
How long has Sanders Capital, LLC held ELV?
Sanders Capital, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sanders Capital, LLC's current position in ELV?
As of Q3 2026, Sanders Capital, LLC holds 5.83M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $2.27B, representing 2.20% of its reported portfolio and ranking #14.
Has Sanders Capital, LLC been buying or selling ELV?
In the latest 13F filing (Q3 2026), Sanders Capital, LLC held unchanged its position in ELV. The position peaked in Q2 2024 at 4.56M shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Harris Associates (Oakmark), among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.